Cycloheximide had no effect on multiplication of the meningopneumonitis agent in L cells in concentrations which eliminated over 90% of the protein synthesis in the host cells. Infected L cells treated with cycloheximide, however, incorporated labeled amino acids into the trichloroacetic acid-insoluble fraction. This The obligate intracellular parasites of the psittacosis group (Chlamydia sp.) exist in two forms (1, 10). The mature extracellular chlamydial cells are small, rugged, and highly infectious, whereas the intracellular reproductive forms are large, fragile, and noninfectious. The most rapid synthesis of protein may be expected to occur in the large, multiplying chlamydial cells. Schechter (14) confirmed this expectation by following the course of protein synthesis in L cells infected with the meningopneumonitis agent by labeling with radioactive lysine at different times after infection and then separating the infected L cells into host and parasite fractions. The rate of protein synthesis in the meningopneumonitis agent reached a peak when the parasite population consisted chiefly of the large, multiplying cell type. However, this method of measuring protein synthesis in the meningopneumonitis agent growing in its L-cell host was not entirely satisfactory, because many of the fragile intracellular meningopneumonitis cells were destroyed during fractionation of the infected L cells. The experiments described in this paper show that cycloheximide, a specific inhibitor of protein synthesis in eucaryotic cells (3), has no effect on multiplication of the meningopneumonitis agent in concentrations which inhibit protein synthesis in L cells. Infected L cells treated with cycloheximide were used to follow meningopneumonitis-specific protein synthesis throughout the course of infection without separating the parasite from its L-cell host.
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MATERIALS AND MErHODS
Growth of L cells. The 5b subline of strain L cells used in previous investigations in this laboratory (7, 14, 21) was employed in all experiments. L cells were propagated in suspension culture in medium 199 (8; Grand Island Biological Co., Grand Island, N.Y.) containing 10% heat-inactivated fetal calf serum (Grand Island Biological Co.) and 100 Ag of streptomycin per ml of medium. Counts of viable cells in suspension cultures were made by the trypan blue exclusion test (6) . Control cultures of uninfected cells were taken from the same stock culture as cells that were infected, treated identically as the infected cells, and suspended to the same final volume and cell density with the same batch of growth medium. Cell densities ranged from 8 X 105 to 1 X 106 cells/ml.
Growth ofmeningopneumonitis agent in L cells. The Cal 10 strain of the meningopneumonitis agent, adapted to growth in L cells by more than 100 serial passages, was grown as previously described (14) . The percentage of infected cells was determined by microscopic examination of L cells stained 20 hr after infection (14) . Multiplicities of infection used in these experiments were approximately 20 Three kinds of inhibitors were tested: (i) puromycin (12) , that interferes with protein synthesis in all kinds of cells; (ii) chlortetracylcine (12) and chloramphenicol (12) , that inhibit synthesis of protein in procaryotic cells; and (iii) cycloheximide (3) , that inhibits protein synthesis in eucaryotic cells. The effects of these inhibitors on multiplication of the meningopneumonitis agent in L cells are given in Fig. 1 in terms of percentage of the uninhibited titer. No infectious meningopneumonitis agent was produced when puromycin was added earlier than 10 hr after infection. There was a progressive release from inhibition when it was added later than 10 hr after infection; complete release occurred earlier with lower concentrations of puromycin. No infectious meningopneumonitis agent was formed in L cells exposed to chloramphenicol or to chlortetracycine during the first 20 hr after infection. Cycloheximide, at a concentration of 2 ,ug/ml, had no effect on meningopneumonitis reproduction when added during the first 20 hr after infection. Other experiments showed that 2 ,ug of cycloheximide per ml was also without effect when added to L cells 2 hr before infection. There was a slight inhibition of multiplication when 5 ,ug of cycloheximide per ml was added early in the infection.
Cycloheximide inhibition of protein synthesis in and incubation at 37 C was continued until 40 hr after infection. The supernatant fluid was then titrated for infectivity in chick embryo yolk sacs by the singledilution method of Golub (4) . Groups of 10 to 15 embryos, 6 to 7 days ofage, were used for each titration. Each LD5o plotted is the mean of two independent observations. The uninhibited meningopneumonitis titer was 108 to 10 LD50 of supernatant fluid per ml.
L cells. Figure 2 shows that as little as 2 ,g of cycloheximide per ml immediately abolished more than 90% of the protein synthesis in L-cell suspensions. A similar result has been reported by Ennis (2).
Synthesis of protein in meningopneumonitisinfected, cycloheximide-treated L cells. Two ,ug of cycloheximide per ml inhibited over 90% of the protein synthesis in L cells and yet had no effect on meningopneumonitis multiplication in these cells. Therefore, it might be predicted that, if, in the presence of cycloheximide, infected L cells would exhibit amino acid incorporation into protein, this incorporation could be ascribed solely to the biosynthetic activities of the meningopneumonitis agent.
One of the first experiments designed to test this prediction is described in the legend to Fig. 3 Fig. 4 , cycloheximideresistant protein synthesis in L cells infected with the meningopneumonitis agent was at its maximum 22 to 24 hr after infection. Thereafter, there was a rapid decrease in the rate of '4C-leucine incorporation, paralleled by an equally rapid decrease in host-cell viability. In contrast, in the experiments summarized in Fig. 5 and 6 After I hr, 0.5 ml of prewarmed medium containing 14C-leucine was added to give a final concentration of 1 iuc/ml. Two hr later, triplicate 0.2-ml samples were removed for determination of "4C-leucine incorporation. The lower halfofFig. 4 plots the 14C-leucine incorporation observed in each 2-hr labeling period; the upper half shows cumulative 14C-leucine uptake and L-cell viability. In plotting the data of this and succeeding figures, no attempt was made to equate counts per minute (cpm) with L-cell numbers, because the cell numbers remained constant throughout the experiments and were the same in comparable infected and uninfected samples.
and its ability to sustain the cycloheximide-insensitive synthesis of protein. The cause of this variation in the rate of host-cell death in response to infection is unknown, but it may result from long-term, periodic changes within the L-cell population.
The data summarized in Fig. 5 may be used to estimate the effect of infection with the meningopneumonitis agent on the rate of host protein synthesis. At all labeling periods, the sum of the incorporation of '4C-leucine into the protein of uninfected L cells and the incorporation into cycloheximide-treated, infected L cells equaled the incorporation into infected but untreated L cells. That is, infection with the meningopneumonitis agent did not inhibit host protein synthesis, and, provided the infected cells remained viable, the cycloheximide-resistant protein synthesis in infected cells took place in addition to the cycloheximide-sensitive protein synthesis normally occurring in the uninfected cells. This additive relationship may be seen most readily by examining the curves for cumulative incorporation into protein.
Inhibition of the cycloheximide-resistant protein synthesis of meningopneumonitis-infected L cells by chloramphenicol and chlortetracycline. The cycloheximide-resistant incorporation of 14C-leucine was almost completely inhibited at all labeling periods when 80 ,ug of chloramphenicol per ml was added to infected L cells 1 hr before the addition of the label (Fig. 6) . In other experiments, 25 ,ug of chlortetracylcine per ml produced a similar inhibition. At these concentrations, neither chloramphenicol nor chlortetracycline inhibited protein synthesis in uninfected, untreated L cells, as measured by incorporation of 14C-leucine into hot trichloroacetic acid-insoluble fractions. Cycloheximide was added I hr before 14C-leucine and 2-hr labeling periods were used. The experiment was performed and the data were plotted as described in Fig. 4 , except that the final concentration of cycloheximide was S ,ug/ml (1.75 X 10-5 m). Experiments of the type summarized in Fig. 5 show that host protein synthesis is not inhibited by infection with the meningopneumonitis agent. Schechter (14) (18) is essential for multiplication of chlamydiae, and these experiments show that synthesis of host protein is also not required. Therefore, the factor provided by the living host cell must be something else. Moulder (9) has suggested that the chlamydiae are energy parasites which pirate the high-energy compounds of their host for their own biosynthetic needs, and there is evidence that adenosine triphosphate is one of these compounds (22) . Since adenosine triphosphate is required for protein synthesis, it is possible that its concentration may become rate-limiting in dead or dying host cells.
The change in the susceptibility of meningopneumonitis multiplication to puromycin during the course of the developmental cycle -arly susceptibility followed by late resistance-is a phenomenon observed with a number of drugs of widely different chemical structures and modes of action: p-fluorophenylalanine (19), 5'-fluorodeoxyuridine (20), 5'-fluorodeoxycytidine (15), aminopterin (13) , actinomycin D (18), cytosine arabinoside (unpublished results), and puromycin aminonucleoside (unpublished results). The causes of the shift in sensitivity to these drugs remains unknown and may be different for each drug, although a single general explanation seems more logical.
Ennis (2) has reported that cycloheximide eventually causes an inhibition of deoxyribonucleic and ribonucleic acid synthesis in L cells. This suggests that the cycloheximide method for following the synthesis of meningopneumonitis protein can be extended to studying the synthesis of other macromolecules in chlamydiae without resort to cell fractionation. It is also possible that cycloheximide-treated host cells may be of value in studying macromolecular syntheses in other procaryotic intracellular parasites.
